BioCentury | Oct 23, 2014
Distillery Therapeutics

Indication: Endocrine/metabolic disease Phase II testing to treat diabetes. Daiichi Sankyo Co. Ltd. has the GPR119 agonist DS-8500...
BioCentury | Jun 5, 2014

Sanford-Burnham goes fourth

...for dyslipidemia Not applicable DS-7309 Glucokinase (GCK; GK) activator Phase I for diabetes Not applicable DS-8500...
Items per page:
1 - 2 of 2